Table 1 Demographic and clinicopathologic characteristics of study cohort

N = 114

N = 105

Median Age (range, y)

60 (30-86)

60 (41-79)

Race

   White

73 (64)

72 (69)

   African American

30 (26)

17 (16)

   Other

11 (10)

16 (15)

Median Serum PSA (ng/ml)

0.9+1.8

5.7 ± 5.1

Clinical Stage

T1c

n/a

74 (70%)

T2a

n/a

26 (25%)

T2b

n/a

1 (1%)

T2c

n/a

2 (2%)

T3a/b

n/a

1 (1%)

T2aNxM1

n/a

1 (1%)

Gleason Score

6

n/a

68 (65%)

7

n/a

23 (22%)

>7

n/a

14 (13%)